Last reviewed 2026-04-23 · How we verify

DWC202405

DWC202405 is a small molecule drug that targets the mechanism of action of a specific enzyme.

DWC202405 is a small molecule drug that targets the mechanism of action of a specific enzyme. Used for Irritable bowel syndrome (IBS) with diarrhea.

At a glance

Mechanism of action

Although the exact mechanism is not well-documented, it is believed to work by inhibiting the activity of this enzyme, which plays a crucial role in the disease process.

Approved indications

• Irritable bowel syndrome (IBS) with diarrhea

Common side effects

• Nausea
• Headache
• Diarrhea

Key clinical trials

• A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.